Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 596967, 12 pages
http://dx.doi.org/10.1155/2014/596967
Research Article

Increased Peripheral Proinflammatory T Helper Subsets Contribute to Cardiovascular Complications in Diabetic Patients

1Department of Endocrinology, Qilu Hospital of Shandong University, Jinan 250012, China
2Institute of Endocrinology and Metabolism, Shandong University, Jinan 250012, China
3Centre for Transplant and Renal Research, Westmead Millennium Institute, The University of Sydney at Westmead Hospital, Westmead, NSW, Australia
4Key Laboratory of Cardiovascular Remodeling and Function Research, Research Center for Cell Therapy, Qilu Hospital of Shandong University, Jinan 250000, China

Received 5 February 2014; Accepted 28 February 2014; Published 3 April 2014

Academic Editor: Dianne Cooper

Copyright © 2014 Ru-xing Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Calle and M. L. Fernandez, “Inflammation and type 2 diabetes,” Diabetes & Metabolism, vol. 38, no. 3, pp. 183–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. T. F. Luscher, M. A. Creager, J. A. Beckman, and F. Cosentino, “Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part II,” Circulation, vol. 108, no. 13, pp. 1655–1661, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Haffner, “The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease,” The American Journal of Cardiology, vol. 97, no. 2, supplement 1, pp. 3A–11A, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Cosmi, L. Maggi, V. Santarlasci, F. Liotta, and F. Annunziato, “T helper cells plasticity in inflammation,” Cytometry A, vol. 85, no. 1, pp. 36–42, 2014. View at Publisher · View at Google Scholar
  5. U. Kintscher, M. Hartge, K. Hess et al., “T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1304–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Kimura and T. Kishimoto, “IL-6: regulator of Treg/Th17 balance,” European Journal of Immunology, vol. 40, no. 7, pp. 1830–1835, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Zhao, D. Tang, S. Yi et al., “Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes,” PLoS ONE, vol. 9, no. 1, article e85770, 2014. View at Publisher · View at Google Scholar
  8. Z. Zhao, Y. Wu, M. Cheng et al., “Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome,” Atherosclerosis, vol. 217, no. 2, pp. 518–524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Cheng, X. Yu, Y. J. Ding et al., “The Th17/Treg imbalance in patients with acute coronary syndrome,” Clinical Immunology, vol. 127, no. 1, pp. 89–97, 2008. View at Publisher · View at Google Scholar
  10. Z. Wang, J. Lee, Y. Zhang et al., “Increased Th17 cells in coronary artery disease are associated with neutrophilic inflammation,” Scandinavian Cardiovascular Journal, vol. 45, no. 1, pp. 54–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. E. Eid, D. A. Rao, J. Zhou et al., “Interleukin-17 and interferon-γ Are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells,” Circulation, vol. 119, no. 10, pp. 1424–1432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Puri, S. E. Nissen, P. Libby et al., “C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy,” Circulation, vol. 128, no. 22, pp. 2395–2403, 2013. View at Publisher · View at Google Scholar
  13. C. J. Packard and Y. Saito, “Non-HDL cholesterol as a measure of atherosclerotic risk,” Journal of Atherosclerosis and Thrombosis, vol. 11, no. 1, pp. 6–14, 2004. View at Google Scholar · View at Scopus
  14. J. C. Pickup and M. A. Crook, “Is type II diabetes mellitus a disease of the innate immune system?” Diabetologia, vol. 41, no. 10, pp. 1241–1248, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. R. N. Poston and D. F. Davies, “Immunity and inflammation in the pathogenesis of atherosclerosis: a review,” Atherosclerosis, vol. 19, no. 3, pp. 353–367, 1974. View at Google Scholar · View at Scopus
  16. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Vendrell, J.-M. Fernandez-Real, C. Gutierrez et al., “A polymorphism in the promoter of the tumor necrosis factor-α gene (−308) is associated with coronary heart disease in type 2 diabetic patients,” Atherosclerosis, vol. 167, no. 2, pp. 257–264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Cesari, B. W. Penninx, A. B. Newman et al., “Inflammatory markers and onset of cardiovascular events: results from the health ABC study,” Circulation, vol. 108, no. 19, pp. 2317–2322, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Shively, D. L. Musselman, and S. L. Willard, “Stress, depression, and coronary artery disease: modeling comorbidity in female primates,” Neuroscience & Biobehavioral Reviews, vol. 33, no. 2, pp. 133–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Meyer, A. Doring, C. Herder, M. Roden, W. Koenig, and B. Thorand, “Dietary patterns, subclinical inflammation, incident coronary heart disease and mortality in middle-aged men from the MONICA/KORA Augsburg cohort study,” European Journal of Clinical Nutrition, vol. 65, no. 7, pp. 800–807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Verdaet, P. Dendale, D. de Bacquer, J. Delanghe, P. Block, and G. de Backer, “Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease,” Atherosclerosis, vol. 176, no. 2, pp. 303–310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. E. A. Miller, J. S. Pankow, R. C. Millikan et al., “Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study,” Atherosclerosis, vol. 171, no. 2, pp. 265–272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Amar, L. Perez, R. Burcelin, and B. Chamontin, “Arteries, inflammation and insulin resistance,” Journal of Hypertension, vol. 24, no. 5, pp. S18–S20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. C. J. Binder, M. K. Chang, P. X. Shaw et al., “Innate and acquired immunity in atherogenesis,” Nature Medicine, vol. 8, no. 11, pp. 1218–1226, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Smith, K. M. Prasad, M. Butcher et al., “Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice,” Circulation, vol. 121, no. 15, pp. 1746–1755, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Mor, G. Luboshits, D. Planer, G. Keren, and J. George, “Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes,” European Heart Journal, vol. 27, no. 21, pp. 2530–2537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Trifari, C. D. Kaplan, E. H. Tran, N. K. Crellin, and H. Spits, “Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells,” Nature Immunology, vol. 10, no. 8, pp. 864–871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. A. Zenewicz and R. A. Flavell, “IL-22 and inflammation: leukin' through a glass onion,” European Journal of Immunology, vol. 38, no. 12, pp. 3265–3268, 2008. View at Publisher · View at Google Scholar · View at Scopus